Eat、Sleep、Console模式管理新生儿戒断综合征的Meta分析
该系统综述与Meta分析纳入12项来自美国的观察性研究,比较Eat、Sleep、Console(ESC)模式与Finnegan新生儿戒断评分系统(FNASS)常规护理对新生儿戒断综合征婴儿结局的影响。结果显示ESC与住院天数减少4.11天及需要戒断药物治疗的比例降低相关,但证据主要来自质量改进和队列研究,出院1周后健康信息几乎缺失。
要点
- ESC模式与住院天数减少4.11天相关(95%CI -6.04至-2.19)。
- ESC模式与接受戒断药物治疗的比例降低相关(OR 0.36,95%CI 0.22至0.60)。
- 证据主要来自质量改进和队列研究,长期结局数据缺乏。
核心结论
- 与FNASS相比,ESC模式可能缩短新生儿戒断综合征婴儿的住院时间并减少戒断药物治疗需求,但证据质量有限。
研究设计与样本
- 系统综述与Meta分析,纳入12项观察性研究(10项质量改进研究、2项队列研究),均来自美国,发表于2018至2024年。
- ESC组n=1877,历史对照FNASS组n=2199;采用随机效应模型合并数据。
- 检索PubMed、Embase、CINAHL和Cochrane,无日期限制,仅纳入英文发表的观察性研究。
主要发现
- ESC组住院天数较FNASS组减少4.11天(MD -4.11天,95%CI -6.04至-2.19天;p<0.0001;I2=95%;10项研究;3703名参与者)。
- ESC组接受戒断药物治疗的比例低于FNASS组(OR 0.36,95%CI 0.22至0.60;I2=89%;RD -0.22,95%CI -0.34至-0.10;p<0.0001;I2=93%;12项研究;4076名参与者)。
- 仅1项研究评估出院后1周内的身体健康,3项评估体重丢失,1项评估费用。
关键数值与推荐
- 主要结局为住院天数、用药天数及接受药物治疗的婴儿比例。
- 研究假设ESC与更短住院时间和更低用药比例相关,基于其与FNASS在婴儿评估上的关键差异。
临床怎么用
- ESC模式可作为FNASS的替代评估护理方式,可能减少新生儿戒断综合征婴儿的住院时间和戒断药物使用。
- 临床应用中需注意现有证据主要来自质量改进和队列研究,出院后长期健康结局信息有限。
局限性
- 纳入研究均为观察性设计(质量改进和队列研究),非随机对照试验。
- 所有研究均来自美国,外推性受限。
- 出院1周后健康信息几乎缺失,缺乏生理应激测量和长期结局数据。
- 异质性高(I2最高达95%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Vigilant clinical assessment is the key to preventing complications, including death, in infants at risk of neonatal withdrawal syndrome. The eat, sleep and console (ESC) is proposed as an alternative to usual care with Finnegan's Neonatal Abstinence Scoring System (FNASS), but whether ESC improves infant outcomes is uncertain. OBJECTIVE: To conduct a meta-analysis and systematic review of outcomes of studies comparing ESC to FNASS. DATA SOURCES: PubMed, Embase, CINAHL and Cochrane were searched. There was no date restriction. STUDY SELECTION: Published data from observational studies published in English were included. Randomised controlled trials, reviews and abstracts were excluded. Data was required to be converted to mean and SD to be included. DATA EXTRACTION AND SYNTHESIS: Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines were used, and data were independently extracted by multiple observers. Data was pooled using a random-effects model. MAIN OUTCOME AND MEASURES: Length of stay (LOS) in days, number of days medicated and proportion of infants medicated were the primary outcomes assessed. It was hypothesised prior to data collection that ESC would be associated with shorter LOS and a lower proportion of infants medicated, given key differences in infant assessment compared with the FNASS. RESULTS: 12 studies, all from the USA, were published between 2018 and 2024. 10 quality improvement studies and two cohort studies compared ESC (n=1877) with historical controls using FNASS (n=2199). ESC decreased hospitalisation days (MD -4.11 days, 95% CI -6.04 to -2.19 days; p<0.0001; I2=95%; 10 studies; 3703 participants) and the proportion treated with withdrawal medications (OR 0.36, 95% CI 0.22 to 0.60; I2=89%; RD -0.22; 95% CI -0.34 to -0.10; p<0.0001; I2=93%; 12 studies; 4076 participants). One study assessed physical health up to 1 week after discharge (n=1), three assessed weight loss (n=3) and one assessed cost (n=1). CONCLUSIONS AND RELEVANCE: The majority of evidence for a reduction in hospitalisation and need for withdrawal medication with ESC compared with FNASS is derived from quality improvement and cohort studies with almost no health information beyond 1 week after discharge. High-quality trials incorporating physiological measurements of infant stress and longer-term outcomes are needed. REVIEW PROSPECTIVE REGISTRATION: CRD42024532169.
引用
- Wei Z, Abdel-Latif ME, Cope J, et al. Eat, sleep and console model of care for managing infants with neonatal abstinence syndrome: a meta-analysis of observational studies. Arch Dis Child. 2025. PMID: 40393782. doi:10.1136/archdischild-2025-328549
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。